2011
DOI: 10.1055/s-0031-1300232
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of Mistletoe (Viscum album L.) Lectins Cytotoxicity by Carbohydrates and Serum Glycoproteins

Abstract: Three D-galactose and/or N-acetyl-D-galactosamine specific mistletoe lectins, ML I, ML II and ML III, were purified by affinity chromatography followed by cation exchange chromatography. These lectins were toxic for Molt 4 cells in culture at concentrations in the pg/ml range, ML III being the most cytotoxic. Carbohydrates able to bind to the B-chain of these lectins inhibited their toxic activity. The digalactosides Gal beta 1,2Gal beta-allyl and Gal beta 1,3Gal beta-allyl were 60 and 30 times, respectively, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
10
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 22 publications
1
10
0
Order By: Relevance
“…Furthermore, Frantz et al . demonstrated, that mistletoe lectins can also bind Serum glycoproteins as haptoglobin, alpha 1-acid glycoprotein and transferrin inhibiting the cytotoxicity of the lectins [62] Although viscumTT had no synergistic effect in vivo , it still demonstrated effectiveness intratumorally and intravenously. To validate the effect of viscumTT in vivo , we injected viscumTT in a patient-derived xenograft model intratumorally and intravenously.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, Frantz et al . demonstrated, that mistletoe lectins can also bind Serum glycoproteins as haptoglobin, alpha 1-acid glycoprotein and transferrin inhibiting the cytotoxicity of the lectins [62] Although viscumTT had no synergistic effect in vivo , it still demonstrated effectiveness intratumorally and intravenously. To validate the effect of viscumTT in vivo , we injected viscumTT in a patient-derived xenograft model intratumorally and intravenously.…”
Section: Discussionmentioning
confidence: 99%
“…For our experiments, we used ML‐I containing aqueous mistletoe extracts from plant material harvested from apple trees, whereas in former investigations, ML‐II/III (Helixor Heilmittel GmbH & Co. KG, Rosenfeld, Germany)‐containing mistletoe extracts harvested from pine and fir trees were used. It is known that ML‐I is significantly less toxic compared to ML‐III (64,65). Moreover, we detected marked difference between extracts concerning tolerance, in vivo .…”
Section: Discussionmentioning
confidence: 99%
“…Mistletoe lectin was isolated and depleted from VAEI by affinity chromatography with immobilized α1-acid glycoprotein. α1-acid glycoprotein was used because of its high and non-selective affinity for all three isoforms of ML [28]. 50 mg of α1-acid glycoprotein (orosomucoid from Sigma-Aldrich, Buchs, Switzerland) was coupled to 2 ml Affi-gel 15 (Bio-Rad, Cressier, Switzerland) according to the manufacturer’s instructions.…”
Section: Methodsmentioning
confidence: 99%